BRCA1 and neoplasm: A recent study of mice carrying a BRCT mutant of BRCA1 that is defective in recognition of phosphorylated proteins and mice carrying an E3 ligase defective mutant of BRCA1 indicates that BRCT phosphoprotein recognition but not the E3 ligase activity is required for BRCA1 tumor suppression [20,21].